Controlled release oral dosage formulations comprising a core and one or more barrier layers

Details for Australian Patent Application No. 2007291509 (hide)

Owner Jagotec AG

Inventors Grenier, Pascal; Nhamias, Alain; Vergnault, Guy

Agent Shelston IP

Pub. Number AU-A-2007291509

PCT Pub. Number WO2008/025535

Priority 60/824,043 30.08.06 US; 60/824,054 30.08.06 US

Filing date 29 August 2007

Wipo publication date 6 March 2008

International Classifications

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/025535 Priority application(s): WO2008/025535

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291514-Heterocyclic FXR binding compounds

2007291508-Preparation and purification of mupirocin calcium